Search clinical trials for: Long COVID19

Total 70187 results

Imperial College London
Hvivo

Completed

COVID-19 SARS-CoV-2 Screening Protocol

Covid19

United Kingdom
Dhaka Medical College

Completed

Clinical Characteristics of Deceased With COVID-19 (COVID-19)

Covid19

Bangladesh
William Beaumont Hospitals

Completed

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

Covid19

United States
University Hospital, Clermont-Ferrand

Unknown

Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT) (COVIDCOLLECT)

Covid19 | Contact Case

France
South Valley University

Completed

Toclizumam Versus Dexamethasone in Severe Covid-19 Cases

Pneumonia, Viral

Egypt
Cairo University

Unknown

Home Management of Adult Egyptian Mild COVID-19 Cases (COVID-19)

Quality of Life | Covid19 | Telemedicine | Safety Issues | Symptoms

Egypt
Javier Hidalgo Tallón
Sociedad Española de Ozonoterapia

Unknown

Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients (OzonoCOVID19)

COVID

Spain
Cairo University

Unknown

Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial

Respiratory Tract Infections
Fondazione Italiana Linfomi - ETS

Recruiting

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance (FIL_FollVax22)

Follicular Lymphoma

Italy
Genova Inc.
Tokyo Shinagawa Hospital

Recruiting

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Covid19

Japan
Semmelweis University Heart and Vascular Center
Semmelweis University Department of Pulmonology; Semmelweis University Medical...

Recruiting

COvid iMaging With POSitron Emission Tomography (COMPOSIT)

Coronavirus Infection

Hungary
Genova Inc.

Recruiting

Novaferon for COVID-19 Treatment Trial (NCTT-005)

Covid19

Japan
AVM Biotechnology Inc
Medpace, Inc.

Not yet recruiting

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS (AVM0703)

Covid19 | Influenza, Human | ARDS
University of Oklahoma
US Department of Veterans Affairs

Completed

Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

Coronavirus Infection | Disease Prevention

United States
Massachusetts General Hospital

Completed

COVID-19 Testing Sample Acquisition Throughput and Efficiency (HexapodBooth)

Covid19 | SARS-CoV Infection | Respiratory Viral Infection | Personal Protective Equipment

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
ClinAmygate

Active, not recruiting

Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up

Covid19 | Corticosteroids

Egypt
Istituto Ortopedico Rizzoli

Completed

Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic Surgery (COVID19&SURG)

Coronavirus Infection | Bone Metastases | Orthopedic Disorder | Bone Neoplasm | Bone Fracture

Italy
Alvea Holdings, LLC

Completed

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Sars-CoV-2 Infection

South Africa
Sona Nanotech Inc

Terminated

Performance Study of SONA Saliva C-19 Rapid Test

Covid19 | Corona Virus Infection | Sars-CoV-2 Infection

Canada
University of Utah
National Institutes of Health (NIH); National Center for Advancing Translational... and other collaborators

Completed

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers

Covid19

United States
Dr. Jurjan Aman
Exvastat Ltd.; Simbec-Orion Group; KABS laboratories

Terminated

Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients (INVENT COVID)

Covid19 | Endothelial Dysfunction | Acute Respiratory Distress Syndrome | ARDS | Pulmonary Edema

Netherlands
Inovio Pharmaceuticals

Withdrawn

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Coronavirus Infection
University of California, Los Angeles
Carnegie Mellon University

Completed

Text-based Reminders to Promote COVID-19 Vaccinations

Covid19, Vaccines

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients (COVIDEYE)

SARS-CoV-2

France
American Hospital of Paris

Completed

Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease

Covid19

France
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Assistance Publique - Hôpitaux de Paris

Terminated

SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism (COVIRIC)

Covid19 | Rheumatoid Arthritis | Spondyloarthritis

France
Université de Sherbrooke
McGill University; Université de Montréal; Université du Québec à Chicoutimi

Completed

Telerehabilitation During Pandemic Containment Measures of COVID19

Stroke

Canada
Istanbul University

Completed

Investigation of the Characteristics of Chronic Pain Developing After COVID-19

Covid19 | Chronic Pain | Coronavirus

Turkey
Daniel Griffin
Eli Lilly and Company; Optum, Inc.

Terminated

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 (UNITED)

Covid19

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents (COVIDIV)

Diabetic Macular Edema | Retinal Vein Occlusion | Age Related Macular Degeneration

France
Sorrento Therapeutics, Inc.

Withdrawn

Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection (US)

COVID-19
Groupe Hospitalier de la Region de Mulhouse et...

Completed

Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 (SISCOVID)

Covid19 | Dyspnea

France
Qiang Hu

Completed

Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19

Covid19 | Lymphopenia

China
King Abdullah International Medical Research Center
Ministry of Health, Saudi Arabia

Completed

Favipiravir Therapy in Adults With Mild COVID-19 (Avi-Mild)

COVID-19

Saudi Arabia
Manuel Taboada Muñiz

Completed

Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 (HIGHLOWDEXA)

Covid19 | Corticosteroids

Spain
Cardiovascular Research Institute Dublin

Active, not recruiting

Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland (SETANTA)

Covid19 | Cardiomyopathies | SARS-CoV Infection

Ireland
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
Niguarda Hospital

Completed

Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients (X-Covid 19)

Covid19

Italy
Meir Medical Center

Completed

the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis

Covid19 | Appendicitis

Israel
Masaryk University
University of Kiel; University of Giessen; F.D. Roosevelt Teaching Hospital with... and other collaborators

Unknown

Oral Side Effects of COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | Oral Manifestations

Czechia, Germany, Slovakia
Centre Hospitalier Régional d'Orléans

Completed

Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test (COVID-VIRO)

Covid19 | SARS-CoV-2 Infection

France
Samaritan Health Services

Completed

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study (GOTCHA)

Coronavirus Infection | Diabetes

United States
Shahid Beheshti University of Medical Sciences
praxisgemeinschaft für zelltherapie

Unknown

Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection

Covid19 | Corona Virus Infection | Treatment

Iran, Islamic Republic of
Rhode Island Hospital
Blackstone Valley Community Health Care

Unknown

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Breast Cancer | Covid19 | Colorectal Cancer

United States
Centre Hospitalier Sud Essonne

Unknown

Prevalence Of COVID-19 Among Health-workers in a French General Hospital (POCAH-COVID)

Covid19

France
Benha University

Completed

Hematology and Clinical Picture in Pediatric COVID-19 Infection

Covid19

Egypt
Central Hospital, Nancy, France

Completed

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

Presence of COVID-19 Compatible CT Abnormalities

France
Tanta University

Unknown

Ivermectin Nasal Spray for COVID19 Patients

Covid19

Search clinical trials for: Long COVID19

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations